Concepedia

Tom J. Parry

TJ

31

Publications

1.3K

Citations

18

H-Index

1990

Active since

Affiliations

Acorda Therapeutics (United States)(Current)

Johnson & Johnson (United States)

Human Genome Sciences (United States)

Temple University

NeuroMetrix (United States)

Tom J. Parry is an author at Acorda Therapeutics (United States) specializing in medicine, pharmacology, and neuroscience.

Top concepts

Publications per year

1990–2018

31

Publications

31

Novel Peptide Inhibitors of Angiotensin-converting Enzyme 2

Lili Huang, Daniel J. Sexton, Kirsten Skogerson et al. · Journal of Biological Chemistry · 2003 · 219 citations · Full text

Albutropin: a growth hormone–albumin fusion with improved pharmacokinetics and pharmacodynamics in rats and monkeys

Blaire L. Osborn, Les Sekut, Marta L. Corcoran et al. · European Journal of Pharmacology · 2002 · 130 citations

, , +7

Drug-eluting stents: Sirolimus and paclitaxel differentially affect cultured cells and injured arteries

Tom J. Parry, Ruth Brosius, Rathna Thyagarajan et al. · European Journal of Pharmacology · 2005 · 120 citations

, , +11

Anti‐Remodeling and Anti‐Fibrotic Effects of the Neuregulin‐1β Glial Growth Factor 2 in a Large Animal Model of Heart Failure

Cristi L. Galindo, Ehab Kasasbeh, Abigail Murphy et al. · Journal of the American Heart Association · 2014 · 82 citations · Full text

Bioactivity of anti-angiogenic ribozymes targeting Flt-1 and KDR mRNA

Tom J. Parry, Cynthia D. Cushman, Adalberto M. Gallegos et al. · Nucleic Acids Research · 1999 · 78 citations · Full text

Rows per page

1–5 of 31